Table of Content


Introduction
Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Overview
Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Therapeutics Development
Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Therapeutics Assessment
Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Companies Involved in Therapeutics Development
Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Drug Profiles
Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Dormant Products
Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Discontinued Products
Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Product Development Milestones
Appendix



List of Figures

List of Figures
Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Top 10 Indications, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Indications, 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products under Investigation by Universities/Institutes, 2021
Products under Investigation by Universities/Institutes, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Pipeline by Actavalon Inc, 2021
Pipeline by Active Biotech AB, 2021
Pipeline by Ampio Pharmaceuticals Inc, 2021
Pipeline by AnTolRx Inc, 2021
Pipeline by Artus Therapeutics Inc, 2021
Pipeline by Aslan Pharmaceuticals Ltd, 2021
Pipeline by Bayer AG, 2021
Pipeline by Dermavant Sciences Inc, 2021
Pipeline by Hercules Pharmaceuticals BV, 2021
Pipeline by Hutchison MediPharma Ltd, 2021
Pipeline by Ikena Oncology Inc, 2021
Pipeline by JAGUAHR Therapeutics Pte Ltd, 2021
Pipeline by Magenta Therapeutics Inc, 2021
Pipeline by Pfizer Inc, 2021
Pipeline by Phenex Pharmaceuticals AG, 2021
Pipeline by Shenogen Pharma?Group Ltd, 2021
Pipeline by Sol-Gel Technologies Ltd, 2021
Pipeline by Welichem Biotech Inc, 2021
Dormant Products, 2021
Dormant Products, 2021 (Contd..1)
Discontinued Products, 2021